[1]Bi, L., Li, J., Shi, Z., et al., 2015. Male accessory breast cancer successfully treated with endocrine therapy: a case report. Oncol. Lett., 10(4):2495-2498.
[2]Burger, A.E., Pain, S.J., Peley, G., 2013. Treatment of recurrent breast cancer following breast conserving surgery. Breast J., 19(3):310-318.
[3]Camisa, C., 1980. Accessory breast on the posterior thigh of a man. J. Am. Acad. Dermatol., 3(5):467-469.
[4]Gao, Y.G., Zhang, S.H., Wang, Y., 2014. A case of accessory mammary cancer in a male patient and a literature review. Eur. J. Gynaecol. Oncol., 35(4):452-455.
[5]Giordano, S.H., Cohen, D.S., Buzdar, A.U., et al., 2004. Breast carcinoma in men: a population-based study. Cancer, 101(1):51-57.
[6]Gou, Z.Y., 1987. Male accessory breast cancer: a case report. Chongqing Med., 16(2):63 (in Chinese).
[7]Gutermuth, J., Audring, H., Voit, C., et al., 2006. Primary carcinoma of ectopic axillary breast tissue. J. Eur. Acad. Dermatol. Venereol., 20(2):217-221.
[8]Hao, J.Y., Yang, C.C., Liu, F.F., et al., 2012. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol. Med., 9(3):197-201.
[9]Jiang, X., 2015. Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 16(1):44-45.
[10]Lin, Y., Wang, Y., 2012. Case report of a male primary breast carcinoma of axillary accessory mammary gland. Clin. Breast Cancer, 12(2):142-144.
[11]Litière, S., Werutsky, G., Fentiman, I.S., et al., 2012. Breast conserving therapy versus mastectomy for stage I‒II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol., 13(4):412-419.
[12]Liu, H.Y., Wang, Y., 2014. Clinical pathological characteristics of male accessory breast cancer: analysis of 1 cases and literature review. Chin. J. Clin. Res., 27(1):83-84 (in Chinese).
[13]Ribeiro, G., Swindell, R., 1992. Adjuvant Tamoxifen for male breast cancer (MBC). Br. J. Cancer, 65(2):252-254.
[14]Takeyama, H., Takahashi, H., Tabei, I., et al., 2010. Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary gland. Breast Cancer, 17(2):151-154.
[15]Yamamura, J., Masuda, N., Kodama, Y., et al., 2012. Male breast cancer originating in an accessory mammary gland in the axilla: a case report. Case Rep. Med., 2012:286210.
[16]Yoshida, Y., Sakakibara, A., Watanabe, T., et al., 2012. Extraordinarily large protruding accessory breast cancer in a man. J. Am. Acad. Dermatol., 67(5):e230-e231.
[17]Zhang, J., Liu, Y., 2008. HER2 over-expression and response to different chemotherapy regimens in breast cancer. J. Zhejiang Univ.-Sci. B, 9(1):5-9.
[18]List of electronic supplementary materials
[19]Fig. S1 Delineation of surgical resection before operation
[20]Fig. S2 Magnetic resonance imaging (MRI) findings of the breast
[21]Fig. S3 Cut-down accessory breast cancer
<2814>
<2133>
ORCID: 
Open peer comments: Debate/Discuss/Question/Opinion
<1>